🔗 Share this article

The prestigious award in Physiology or Medicine has been awarded for revolutionary discoveries that illuminate how the immune system attacks harmful infections while protecting the body's own cells.

A trio of esteemed researchers—from Japan Prof. Sakaguchi and US experts Mary Brunkow and Fred Ramsdell—received this honor.

The work identified specialized "sentinels" within the immune system that remove rogue immune cells capable of attacking the body.

These findings are now paving the way for innovative therapies for autoimmune diseases and cancer.

The winners will share a monetary award valued at 11 million SEK.

Crucial Discoveries

"Their research has been essential for comprehending how the body's defenses functions and the reason we don't all develop severe self-attack conditions," stated the head of the award panel.

This trio's research explain a core question: In what way does the defense system defend us from numerous invaders while keeping our own tissues unharmed?

The immune system employs white blood cells that search for signs of infection, including pathogens and bacteria it has not met before.

Such defenders utilize detectors—called recognition units—that are generated by chance in a vast number of variations.

That gives the immune system the capacity to fight a broad range of threats, but the randomness of the mechanism inevitably creates immune cells that may attack the host.

Protectors of the Body

Scientists earlier understood that a portion of these problematic white blood cells were eliminated in the thymus—the site where white blood cells mature.

This year's Nobel Prize recognizes the identification of T-reg cells—known as the body's "peacekeepers"—which patrol the body to neutralize other defenders that assault the body's own tissues.

It is known that this mechanism fails in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel stated, "The findings have established a novel area of research and spurred the development of innovative therapies, for example for cancer and immune disorders."

Regarding cancer, T-regs prevent the system from fighting the growth, so research are focused on lowering their quantity.

For autoimmune diseases, trials are exploring boosting T-reg cells so the body is not being harmed. A similar approach could also be useful in reducing the chances of organ transplant rejection.

Innovative Studies

Professor Sakaguchi, of a Japanese institution, performed experiments on rodents that had their thymus extracted, leading to autoimmune disease.

He demonstrated that introducing immune cells from healthy mice could prevent the disease—implying there was a system for preventing immune cells from harming the body.

Mary Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were studying an inherited immune disorder in rodents and people that led to the discovery of a gene vital for how regulatory T-cells operate.

"The groundbreaking research has uncovered how the body's defenses is controlled by regulatory T cells, stopping it from mistakenly targeting the body's own tissues," said a prominent physiology specialist.

"This work is a remarkable example of how fundamental physiological research can have broad implications for human health."